Former Biomet CEO joins Minimus Spine board of directors

Spinal Tech

Minimus Spine appointed Jeffrey R. Binder to its board of directors.

Minimus Spine manufactures the Triojection system for herniated spinal discs. The company is dedicated to non-surgical treatment of herniated discs.


Mr. Binder was Biomet's CEO from 2007 to 2015, when Zimmer acquired the company for $14 billion. He also has experience as president of Abbot Diagnostics and CEO of Spinal Concepts. He is currently the president and CEO of Immucor.


"Jeff brings a wealth of intellect and experience to Minimus," said David Hooper, PhD, President and CEO of Minimus Spine. "He has successfully orchestrated several significant transactions in spine and orthopedics and is unquestionably a blue-chip addition as we strengthen the team around Triojection."


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers